Phase I Study of Pazopanib in Combination With Vinorelbine in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Breast Cancer.

Trial Profile

Phase I Study of Pazopanib in Combination With Vinorelbine in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Breast Cancer.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 29 Oct 2013

At a glance

  • Drugs Pazopanib (Primary) ; Vinorelbine (Primary)
  • Indications Advanced breast cancer; Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Sep 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 17 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 27 Jul 2011 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top